Publications by authors named "Rocio Cardona"

Article Synopsis
  • This study investigates how often psoriasis patients stop their biologic therapy and looks at the demographics and health characteristics of these patients.
  • A total of 77 psoriasis patients who had discontinued biologic therapy at least once were analyzed, revealing that common comorbidities included hypertension and diabetes, while adalimumab and ustekinumab were the most used biologics.
  • The main reason for stopping therapy was lack of effectiveness, with insurance coverage also affecting the discontinuation of certain biologics; findings showed no significant links between therapy discontinuation and patient demographics.
View Article and Find Full Text PDF

Tuberous sclerosis complex (TSC) is a neurocutaneous disease characterized by cutaneous and extracutaneous hamartomas. Dermatologic evaluation is critical for early diagnosis because mucocutaneous manifestations account for 4 of 11 major and 3 of 6 minor diagnostic criteria. Folliculocystic and collagen hamartoma (FCCH) is a recently described entity associated with TSC.

View Article and Find Full Text PDF

Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and potentially life-threatening mucocutaneous reactions. Given their rarity, limited cohort studies have been done. The aim of this study is to evaluate and compare the demographics, etiology, management, clinical and laboratory characteristics, complications, and outcome of SJS/TEN patients seen by the inpatient dermatology service at the University of Puerto Rico.

View Article and Find Full Text PDF

Objective: To describe the behavior of non-melanoma skin cancer (NMSC) based on tumor's characteristics.

Methods: A total of 219 of NMSC were analyzed via a retrospective medical chart review. The data obtained from each record included but was not limited to: number of Mohs micrographic surgery (MMS) stages required for tumor clearance, defect size, repair type and size according to the neoplasm's histopathologic subtype.

View Article and Find Full Text PDF

FPrecursor T- or B-cell non-Hodgkin lymphoblastic lymphomas represent only a small fraction of pediatric cancer cases. Due to its rarity, the diagnosis of lymphoblastic lymphoma (LBL) in a pediatric patient is challenging, particularly if its manifestation is solely cutaneous. We describe the case of an infant with primary cutaneous B-cell LBL who was initially diagnosed by a primary care physician with an infectious etiology and consequently treated with topical and oral antibiotics.

View Article and Find Full Text PDF